Conference Preview|Gluetacs to Present at Biotechnology in America 2024 (BIO)

ON：2024-05-30 TAG：GLUETACS THERAPEUTICS

On May 30, 2024, Gluetacs Therapeutics, an innovative clinical-stage biopharmaceutical technology enterprise specializing in protein degradation technology, announced that it will participate in the BIO International Convention held in San Diego, California, USA, from June 3 to 6, 2024 (PT). Robert Sons, Head of Business Development, North America of Gluetacs, will attend the conference and present a company showcase at 4:30 PM on June 4, 2024 (PT). He will share the proprietary R&D platform in targeted protein degradation and preliminary results of clinical and pre-clinical pipelines, and explore cooperation opportunities.

The BIO International Convention, founded in 1993, is the largest, most professional, and most influential biotechnology event globally. It is held in different cities in the United States every year, attracting professionals from the global biotechnology industry, including pharmaceutical companies, biotechnology companies, life science research institutions, medical device companies, bio-manufacturers, governments, and academic institutions. The convention is hosted by the Biotechnology Innovation Organization, the world’s largest biotechnology industry association representing biotechnology companies, academic institutions, and related organizations, whose members cover the United States and 30 other countries.

Gluetacs cordially invites you to interact with us at BIO 2024. You can contact us via email (bd@gluetacs.com) and meet our team at BIO 2024.